Physician profile
Vikas Batra
NPI 1508804907
$16,659.04
in general payments reported to CMS, 2019-2025
53 companies · $2,833 in 2025
The $2,833 reported for 2025 was more than what 82% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,754 · 2020: $491 · 2021: $826 · 2022: $1,375 · 2023: $2,321 · 2024: $7,058 · 2025: $2,833.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,466 · Education: $4,465 · Travel and Lodging: $932 · Consulting Fee: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,465.78 |
| Education | $4,464.83 |
| Travel and Lodging | $932.00 |
| Consulting Fee | $350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,701.37 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $1,702.56 | 2019-2025 | Breztri, Fasenra, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,213.38 | 2019-2025 | Jardiance, Ofev, Stiolto Respimat |
| Glaxosmithkline, LLC. | $873.50 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Jazz Pharmaceuticals INC. | $649.61 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $598.37 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Harmony Biosciences LLC | $407.63 | 2023-2025 | Wakix |
| Inspire Medical Systems, INC. | $397.32 | 2024 | Inspire |
| Insmed, INC. | $363.94 | 2019-2025 | Arikayce |
| Genzyme Corporation | $351.63 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $349.43 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $302.62 | 2019-2024 | |
| Novo Nordisk INC | $302.57 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $292.89 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| United Therapeutics Corporation | $285.92 | 2019-2025 | Tyvaso, Tyvaso |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $278.20 | 2019-2025 | Xolair |
| Mallinckrodt Hospital Products INC. | $246.10 | 2020-2024 | Acthar |
| Mylan Specialty L.P. | $244.16 | 2019-2024 | Yupelri |
| Avadel Cns Pharmaceuticals, LLC | $243.16 | 2024-2025 | Lumryz |
| Zoll Respicardia, INC. | $237.81 | 2023 | Remede System |
| Merck Sharp & Dohme LLC | $232.52 | 2021-2025 | Winrevair, Keytruda |
| Grifols USA, LLC | $187.31 | 2019-2025 | Prolastin-C Liquid |
| Axsome Therapeutics, INC. | $185.29 | 2023-2025 | Sunosi |
| Takeda Pharmaceuticals U.S.A., INC. | $180.10 | 2020-2025 | Glassia |
| Ani Pharmaceuticals, INC. | $155.31 | 2023-2025 | Purified Cortrophin Gel |
| Sanofi-Aventis U.S. LLC | $150.84 | 2020-2025 | |
| Dexcom, INC. | $137.25 | 2023-2025 | Dexcom G6 Transmitter |
| Amgen INC. | $130.88 | 2019-2025 | Tezspire |
| Regeneron Healthcare Solutions, INC. | $123.72 | 2019-2024 | Dupixent |
| Mallinckrodt Enterprises LLC | $110.05 | 2019 | |
| Boston Scientific Corporation | $106.57 | 2021 | |
| Sunovion Pharmaceuticals INC. | $97.59 | 2019-2020 | |
| Baxter Healthcare | $93.43 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Volara System |
| Viatris Specialty LLC | $73.62 | 2025 | Yupelri |
| Electromed, INC. | $67.55 | 2022-2025 | Smartvest |
| Resmed Corp | $60.40 | 2019-2024 | |
| Verona Pharma, INC. | $57.37 | 2025 | Ohtuvayre |
| Insulet Corporation | $55.43 | 2022-2024 | Omnipod |
| Corcept Therapeutics | $51.44 | 2025 | Korlym |
| Pfizer INC. | $46.12 | 2023-2024 | |
| Tactile Systems Technology INC | $43.19 | 2025 | Nimbl, Flexitouch Plus |
| Philips North America LLC | $39.78 | 2020-2025 | Patient Interface Software |
| Shire North American Group INC | $34.03 | 2019 | |
| Circassia INC. | $33.71 | 2019 | |
| Tandem Diabetes Care, INC. | $27.51 | 2019 | |
| Abbott Laboratories | $23.65 | 2021 | |
| Abbvie INC. | $18.72 | 2021 | |
| Pulmonx Corporation | $18.07 | 2023 | Pulmonx Chartis Tablet Console, Chartis Catheter, Zephyr Endobronchial Valve |
| Lifescan, INC. | $17.00 | 2020 | |
| Cequr Corporation | $16.12 | 2023 | Cequr Simplicity |
| Eisai INC. | $14.79 | 2021 | |
| Alexion Pharmaceuticals, INC. | $13.99 | 2024 | Strensiq |
| Janssen Pharmaceuticals, INC | $13.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikas Batra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.